222 related articles for article (PubMed ID: 3071329)
1. Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection.
Mitsuyasu RT; Golde DW
Behring Inst Mitt; 1988 Aug; (83):139-44. PubMed ID: 3071329
[TBL] [Abstract][Full Text] [Related]
2. The use of myeloid hematopoietic growth factors in patients with HIV infection.
Mitsuyasu RT; Miles SA; Golde DW
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():347-54; discussion 354-5. PubMed ID: 1691250
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte macrophage colony stimulating factor (GM-CSF) in AIDS.
Scadden DT
Prog Clin Biol Res; 1990; 338():163-76. PubMed ID: 2189138
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor in human immunodeficiency virus disease.
Groopman JE
Semin Hematol; 1990 Jul; 27(3 Suppl 3):8-14. PubMed ID: 2198662
[TBL] [Abstract][Full Text] [Related]
5. Clinical role of granulocyte-macrophage colony-stimulating factor.
Mitsuyasu RT; Golde DW
Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of recombinant DNA granulocyte macrophage colony stimulating factor.
Steward WP; Scarffe JH; Austin R; Crowther D
Behring Inst Mitt; 1988 Aug; (83):324-6. PubMed ID: 3071348
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic growth factors: biology and clinical application.
Gabrilove JL; Jakubowski A
J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
Rifkin RM; Hersh EM; Salmon SE
Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
[TBL] [Abstract][Full Text] [Related]
9. The effects of recombinant human granulocyte-macrophage colony-stimulating factor on phagocyte kinetics in man.
Linch DC; Devereux S; Addison IE
Behring Inst Mitt; 1988 Aug; (83):320-3. PubMed ID: 3071347
[TBL] [Abstract][Full Text] [Related]
10. Yeast-expressed granulocyte-macrophage colony-stimulating factor in cancer patients: a phase ib clinical study.
Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
Behring Inst Mitt; 1988 Aug; (83):107-18. PubMed ID: 2467645
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes.
Hoelzer D; Ganser A; Völkers B; Greher J; Walther F
Blood Cells; 1988; 14(2-3):551-9. PubMed ID: 3067785
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II study with GM-CSF in patients with myelodysplastic syndromes.
Hoelzer D; Ganser A; Greher J; Völkers B; Walther F
Behring Inst Mitt; 1988 Aug; (83):134-8. PubMed ID: 3071328
[TBL] [Abstract][Full Text] [Related]
13. Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor.
Lynch M; Yanes L; Todd K
Oncol Nurs Forum; 1988; 15(4):463-9. PubMed ID: 3041383
[No Abstract] [Full Text] [Related]
14. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
15. The clinical use of hematopoietic growth factors.
Appelbaum FR
Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
[TBL] [Abstract][Full Text] [Related]
16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
[TBL] [Abstract][Full Text] [Related]
18. Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation.
Blazar BR; Widmer MB; Kersey JH; Ramsay NK; McGlave PB; Urdal DL; Gillis S; Henney C; Vallera DA
Behring Inst Mitt; 1988 Aug; (83):170-80. PubMed ID: 3071335
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of recombinant human colony-stimulating factors.
Klingemann HG
CMAJ; 1989 Jan; 140(2):137-42. PubMed ID: 2642725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]